About
Pharmocann develops and produces Israeli medical cannabis on a farm located in the valley of Jezreel, the Galilee. The farm has hothouses for cannabis growth and propagation; a hothouse for the research and development of various cannabis strains; and other facilities required for the cultivation, harvesting, and production of medical cannabis.
The company is also a developer of medical marijuana cultivation centers and dispensaries. Pharmocann has established a strategic partnership with medical cannabis labs to produce standardized, validated, and GMP-manufactured medical cannabis products. Its line of products includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.
Pharmocann’s latest developments include hydrogel products for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowl diseases. Pharmocann serves more than 3,000 patients a month and yields about two tons of medical cannabis yearly.
Funding history · 1 round · $690K total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When did Pharmocann become a public company?
- Pharmocann became a public company in December 2018 through a reverse merger on the TASE.
- What was Pharmocann's most recent funding round?
- Pharmocann's most recent funding round was a PIPE in April 2019, raising $690,000. Cybele Holdings was a lead investor.
- What is Pharmocann's primary business activity?
- Pharmocann develops and produces Israeli medical cannabis on a farm in the Jezreel Valley, Galilee, focusing on cultivation, harvesting, and production of medical cannabis products.
- What types of medical cannabis products does Pharmocann offer?
- Pharmocann's product line includes oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various THC/CBD strains.
- What new product developments has Pharmocann recently focused on?
- Pharmocann's latest developments include hydrogel products designed for the treatment of certain painful diseases, acute dermatological diseases, and inflammatory bowel diseases.
- How many patients does Pharmocann serve monthly and what is its annual yield?
- Pharmocann serves over 3,000 patients a month and yields approximately two tons of medical cannabis yearly.
- Did Pharmocann experience any operational issues in July 2022?
- In July 2022, a fungus affected Pharmocann's cannabis, and the CEO unexpectedly departed.
- What strategic partnership did Pharmocann establish in November 2021?
- In November 2021, Pharmocann teamed with Shamir Institute to work on magic mushrooms.
- What was a significant event for Pharmocann in November 2018?
- In November 2018, WeedMD exported cannabis genetics to Pharmocann in Israel.